Theoretical aspects of autism: Causes—A review

References

• Advisory Committee on Immunization Practices. 2004. http://www.cdc.gov/nip/acip
   Google Scholar
• Advisory Committee on Immunization Practices. 2010. http://www.cdc.gov/vaccines/recs/acip
   Google Scholar
• Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., and Zoghbi, H. Y. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23:185–188.
   PubMed Web of Science ®Google Scholar
• Atladóttir, H. O., Thorsen, P., Østergaard, L., Schendel, D. E., Lemcke, S., Abdallah, M., and Parner, E. T. 2010. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 40:1423–1430.
   PubMed Web of Science ®Google Scholar
• Auyeung, B., Baron-Cohen, S., Ashwin, E., Knickmeyer, R., Taylor, K., and Hackett, G. 2009. Fetal testosterone and autistic traits. Br. J. Psychol. 100:1–22.
   PubMed Web of Science ®Google Scholar
• Aylward, E. H., Minshew, N. J., Field, K., Sparks, B. F., and Singh, N. 2002. Effects of age on brain volume and head circumference in autism. Neurology. 59:175–183.
   PubMed Web of Science ®Google Scholar
• Ayoub, D. J., and Yazbak, F. E. 2006. Influenza vaccination during pregnancy: A critical assessment of the recommendations of the advisory committee on immunization practices (ACIP). J. Am. Phys. Surg. 11:41–47.
   Google Scholar
• Baieli, S., Pavone, L., Meli, C., Fiumara, A., and Coleman, M. 2003. Autism and phenylketonuria. J. Autism Dev. Disord. 33:201–204.
   PubMed Web of Science ®Google Scholar
• Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., and Charman, T. 2006. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet. 368:210–215.
   PubMed Web of Science ®Google Scholar
• Barbaresi, W. J., Katusic, S. K., and Voigt, R. G. 2006. Autism: a review of the state of the science for pediatric primary health care clinicians. Arch. Pediatr. Adolesc. Med. 160:1167–1175.
   PubMed Web of Science ®Google Scholar
• Baron-Cohen, S. 1999. The extreme-male-brain theory of autism. In: Neurodevelopmental Disorders (Tager-Flusberg, H., Ed.). Boston: MIT Press, pp. 1–68.
   Google Scholar
• Baron-Cohen, S., and Hammer, J. 1997. Is autism an extreme form of the “male brain”? Adv. Infancy Res. 11:193–217.
   Google Scholar
• Baron-Cohen, S., Scott, F. J., Allison, C., Williams, J., Bolton, P., Matthews, F. E., and Brayne, C. 2009. Prevalence of autism-spectrum conditions: UK school-based population study. Br. J. Psychiatry. 194:500–509.
   PubMed Web of Science ®Google Scholar
• Baskin, D. S., Ngo, H., and Didenko, V. V. 2003. Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. Toxicol. Sci. 74:361–368.
   PubMed Web of Science ®Google Scholar
• Bauman, M. L., and Kemper, T. L. (Eds). 1994. Neuro-anatomic observations of the brain in autism. In: The Neurobiology of Autism, Baltimore: Johns Hopkins University Press, pp. 119–145.
   Google Scholar
• Bauman, M. L., and Kemper, T. L. 2005. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 23:183–187.
   PubMed Web of Science ®Google Scholar
• Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., Bonin, M., Riess, A., Engels, H., Sprengel, R., Scherer, S. W., and Rappold, G. A. 2010. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42:489–491.
   PubMed Web of Science ®Google Scholar
• Bernard, S., Enayati, A., Redwood, L., Roger, H., and Binstock, T. 2001. Autism: a novel form of mercury poisoning. Med. Hypotheses. 56:462–471.
   PubMed Web of Science ®Google Scholar
• Binstock, T. 2001. Intra-monocyte pathogens delineate autism subgroups. Med. Hypotheses. 56:523–531.
   Google Scholar
• Bouchard, M. F., Bellinger, D. C., Wright, R. O., and Weisskopf, M. G. 2010. Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics. 125:e1270–e1277.
   PubMed Web of Science ®Google Scholar
• Brabin, R. J. 1985. Epidemiology of infection in pregnancy. Rev. Infect. Dis. 7:579–603.
   PubMedGoogle Scholar
• Breuer, J. 2003. Live attenuated vaccine for the prevention of varicella-zoster virus infection: does it work, is it safe and do we really need it in the UK? J. Med. Microbiol. 52:1–3.
   Google Scholar
• Bryson, S. E., and Smith, I. M. 1998. Epidemiology of autism: Prevalence, associated characteristics, and implications for research and service delivery. Mental Retard. Dev. Disab. Res. Rev. 4:97–103.
   Google Scholar
• Caglayan, A. O. 2010. Genetic causes of syndromic and non-syndromic autism. Dev. Med. Child Neurol. 52:130–138.
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention. 2010. http://www.cdc.gov/ncbddd/autism/data.html.
   Google Scholar
• Chauhan, A., and Chauhan, V. 2006. Oxidative stress in autism. Pathophysiology. 13:171–181.
   PubMedGoogle Scholar
• Chess, S. 1971. Autism in children with congenital rubella. J. Autism Child. Schizophr. 1:33–47.
   PubMedGoogle Scholar
• Chess, S. 1977. Follow-up report on autism in congenital rubella. J. Autism Child. Schizophr. 7:69–81.
   PubMedGoogle Scholar
• Chez, M. G., and Guido-Estrada, N. 2010. Immune therapy in autism: historical experience and future directions with immunomodulatory therapy. Neurotherapeutics. 7:293–301.
   PubMed Web of Science ®Google Scholar
• Child Health Safety. 2010. June 30.
   Google Scholar
• Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., and Chugani, H.T.. 1999. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45:287–295.
   PubMed Web of Science ®Google Scholar
• Clifford, P. M., Zarrabi, S., Siu, G., Kinsler, K. J., Kosciuk, M. C., Venkataraman, V., D’Andrea, M. R., Dinsmore, S., and Nagele, R. G. 2007. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res. 1142:223–236.
   PubMed Web of Science ®Google Scholar
• Coleman, M., and Betancur, C. 2005. Introduction In: The Neurology of Autism (Coleman, M., Ed.), New York: Oxford University Press, pp. 3–39.
   Google Scholar
• Courchesne, E. 1997. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr. Opin. Neurobiol. 7:269–278.
   PubMed Web of Science ®Google Scholar
• Courchesne, E., Karns, C. M., Davis, H. R., Ziccardi, R., Carper, R. A., Tigue, Z. D., Chisum, H. J., Moses, P., Pierce, K., Lord, C., Lincoln, A. J., Pizzo, S., Schreibman, L., Haas, R. H., Akshoomoff, N. A., and Courchesne, R. Y. 2001. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology. 57:245–254.
   PubMed Web of Science ®Google Scholar
• Courchesne, E., Carper, R., and Akshoomoff, N. 2003. Evidence of brain overgrowth in the first year of life in autism. JAMA. 290:337–344.
   PubMed Web of Science ®Google Scholar
• Croen, L. A., Najjar, D. V., Fireman, B., and Grether, J. K. 2007. Maternal and paternal age and risk of autism spectrum disorders. Arch. Pediatr. Adolesc. Med. 161:334–340.
   PubMed Web of Science ®Google Scholar
• DeFrancesco, L. 2001. Autism on the rise. The Scientist 15:16–19.
   Web of Science ®Google Scholar
• Deisher, T. 2010. Personal communication.
   Google Scholar
• DeLong, G. R., Bean, S. C., and Brown, F.R. 3rd. 1981. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch. Neurol. 38:191–194.
   PubMedGoogle Scholar
• DeSoto, M. C. 2009. Ockham’s Razor and autism: the case for developmental neurotoxins contributing to a disease of neurodevelopment. Neurotoxicology. 30:331–337.
   PubMedGoogle Scholar
• Desoto, M. C., and Hitlan, R. T. 2007. Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set. J. Child Neurol. 22:1308–1311.
   PubMed Web of Science ®Google Scholar
• DeStefano, F. 2007. Vaccines and autism: evidence does not support a causal association. Clin. Pharmacol. Ther. 82:756–759.
   PubMed Web of Science ®Google Scholar
• Diem, K. (Ed). 1962. Documenta Geigy Scientific Tables. Edition 6., Ardsley, NY: Geigy Pharmaceuticals.
   Google Scholar
• Dietert, R. R., and Dietert, J. M. 2008. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability. J. Toxicol. Environ. Health. B. Crit. Rev. 11:660–680.
   PubMed Web of Science ®Google Scholar
• Dufault, R., Schnoll, R., Lukiw, W. J., Leblanc, B., Cornett, C., Patrick, L., Wallinga, D., Gilbert, S. G., and Crider, R. 2009. Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children. Behav. Brain Funct. 5:44.
   PubMed Web of Science ®Google Scholar
• Dziobek, I., Bahnemann, M., Convit, A., and Heekeren, H. R. 2010. The role of the fusiform-amygdala system in the pathophysiology of autism. Arch. Gen. Psychiatry. 67:397–405.
   Google Scholar
• Ecker, C., Marquand, A., Mourão-Miranda, J., Johnston, P., Daly, E. M., Brammer, M. J., Maltezos, S., Murphy, C. M., Robertson, D., Williams, S. C., and Murphy, D. G. 2010. Describing the brain in autism in five dimensions–magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach. J. Neurosci. 30:10612–10623.
   PubMed Web of Science ®Google Scholar
• Farfel, Z., Bourne, H. R., and Iiri, T. 1999. The expanding spectrum of G protein diseases. N. Engl. J. Med. 340:1012–1020.
   PubMed Web of Science ®Google Scholar
• Farzin, F., Perry, H., Hessl, D., Loesch, D., Cohen, J., Bacalman, S., Gane, L., Tassone, F., Hagerman, P., and Hagerman, R. 2006. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J. Dev. Behav. Pediatr. 27:S137–S144.
   PubMed Web of Science ®Google Scholar
• Fatemi, S. H. 2002. The role of Reelin in pathology of autism. Mol. Psychiatry. 7:919–920.
   Google Scholar
• Fatemi, S. H. 2005. Reelin glycoprotein in autism and schizophrenia. Int. Rev. Neurobiol. 71:179–187.
   Google Scholar
• Fatemi, S. H., Snow, A. V., Stary, J. M., Araghi-Niknam, M., Reutiman, T. J., Lee, S., Brooks, A. I., and Pearce, D. A. 2005. Reelin signaling is impaired in autism. Biol. Psychiatry. 57:777–787.
   PubMed Web of Science ®Google Scholar
• Fombonne, E. 1999. The epidemiology of autism: a review. Psychol. Med. 29:769–786.
   PubMed Web of Science ®Google Scholar
• Fombonne, E. 2001. Is there an epidemic of autism? Pediatrics. 107:411–412.
   PubMed Web of Science ®Google Scholar
• Freeman, S. J., Roberts, W., and Daneman, D. 2005. Type 1 diabetes and autism: is there a link? Diabetes Care. 28:925–926.
   Google Scholar
• Ganz, M. L. 2007. The lifetime distribution of the incremental societal costs of autism. Arch. Pediatr. Adolesc. Med. 161:343–349.
   PubMed Web of Science ®Google Scholar
• Garreau, B., Barthelemy, C., Sauvage, D., Leddet, I., and LeLord, G. 1984. A comparison of autistic syndromes with and without associated neurological problems. J. Autism Dev. Disord. 14:105–111.
   PubMedGoogle Scholar
• Geier, D. A., Audhya, T., Kern, J. K., and Geier, M. R. 2010. Blood mercury levels in autism spectrum disorder: Is there a threshold level? Acta Neurobiol. Exp. (Wars). 70:177–186.
   Web of Science ®Google Scholar
• Geier, D. A., and Geier, M. R. 2006. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox. Res. 10:57–64.
   PubMed Web of Science ®Google Scholar
• Geier, D. A., and Geier, M. R. 2006. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm. Res. 66:182–188.
   PubMed Web of Science ®Google Scholar
• Geier, D. A., Kern, J. K., Garver, C. R., Adams, J. B., Audhya, T., Nataf, R., and Geier, M. R. 2009. Biomarkers of environmental toxicity and susceptibility in autism. J. Neurol. Sci. 280:101–108.
   PubMed Web of Science ®Google Scholar
• Geier, D. A., Sykes, L. K., and Geier, M. R. 2007. A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J. Toxicol. Environ. Health. B. Crit. Rev. 10:575–596.
   PubMed Web of Science ®Google Scholar
• Gillberg, C. 1986. Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis. J. Autism Dev. Disord. 16:369–375.
   PubMed Web of Science ®Google Scholar
• Gillberg, I. C. 1991. Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for childhood autism. Dev. Med. Child Neurol. 33:920–924.
   PubMed Web of Science ®Google Scholar
• Goldman, G. S., and Yazbak, F. E. 2004. An investigation of the association between MMR vaccination and autism in Denmark. J. Am. Physic. Surg. 9:70–75.
   Google Scholar
• Good, P. 2009. Did acetaminophen provoke the autism epidemic? Altern. Med. Rev. 14:364–372.
   Google Scholar
• Grether, J. K., Anderson, M. C., Croen, L. A., Smith, D., and Windham, G. C. 2009. Risk of autism and increasing maternal and paternal age in a large north American population. Am. J. Epidemiol. 170:1118–1126.
   PubMed Web of Science ®Google Scholar
• Haas, R. H. 2010. Autism and mitochondrial disease. Dev. Disabil. Res. Rev. 16:144–153.
   PubMedGoogle Scholar
• Halsey, N. A., Hyman, S. L., and the Conference Writing Panel. 2001. Measles-Mumps-Rubella vaccine and autistic spectrum disorder: Report from the new challenges in childhood immunizations conference convened in Oak Brook, Illinois, June 12-13, 2000. Pediatrics 107:e84–e106.
   Google Scholar
• Havarinasab, S., and Hultman, P. 2005. Organic mercury compounds and autoimmunity. Autoimmun. Rev. 4:270–275.
   PubMed Web of Science ®Google Scholar
• Hook, E. B. 1981. Rates of chromosome abnormalities at different maternal ages. Obstet. Gynecol. 58:282–285.
   PubMed Web of Science ®Google Scholar
• Jacobson, J. L., Jacobson, S. W., Padgett, R. J., Brumitt, G. A., and Billings, R. L. 1992. Effects of prenatal PCB exposure on cognitive processing efficiency and sustained attention. Dev. Psychol. 28:297–306.
   Web of Science ®Google Scholar
• James, S. J., Slikker, W. 3rd, Melnyk, S., New, E., Pogribna, M., and Jernigan, S. 2005. Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology. 26:1–8.
   PubMed Web of Science ®Google Scholar
• Jepson, B. (Ed). 2007a. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 42–46.
   Google Scholar
• Jepson, B. (Ed). 2007b. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 176–180.
   Google Scholar
• Jepson, B. (Ed). 2007c. Changing the Course of Autism. Boulder, CO: Sentient Publications, pp. 56–64.
   Google Scholar
• Johnson, S. 2000. Understand what you’re facing In: Facing Autism (Hamilton, L. M., Ed.), Colorado Springs, CO: WaterBrook Press, pp. 39–60.
   Google Scholar
• Kanner, L. 1943. Autistic disturbances of affective contact. Nervous Child 2:217–250.
   Google Scholar
• Kempuraj, D., Asadi, S., Zhang, B., Manola, A., Hogan, J., Peterson, E., and Theoharides, T.C. 2010. Mercury induces inflammatory mediator release from human mast cells. J. Neuroinflammation. 7:20.
   PubMed Web of Science ®Google Scholar
• Kidd, P. M. 2002. Autism, an extreme challenge to integrative medicine. Part: 1: The knowledge base. Altern. Med. Rev. 7:292–316.
   PubMedGoogle Scholar
• Kim, B. N., Cho, S. C., Kim, Y., Shin, M. S., Yoo, H. J., Kim, J. W., Yang, Y. H., Kim, H. W., Bhang, S. Y., and Hong, Y. C. 2009. Phthalates exposure and attention-deficit/hyperactivity disorder in school-age children. Biol. Psychiatry. 66:958–963.
   PubMed Web of Science ®Google Scholar
• Knickmeyer, R. C., and Baron-Cohen, S. 2006. Fetal testosterone and sex differences in typical social development and in autism. J. Child Neurol. 21:825–845.
   PubMed Web of Science ®Google Scholar
• Knickmeyer, R., Baron-Cohen, S., Raggatt, P., and Taylor, K. 2005. Foetal testosterone, social relationships, and restricted interests in children. J. Child Psychol. Psychiatry. 46:198–210.
   PubMed Web of Science ®Google Scholar
• Knickmeyer, R., Baron-Cohen, S., Fane, B. A., Wheelwright, S., Mathews, G. A., Conway, G. S., Brook, C. G., and Hines, M. 2006. Androgens and autistic traits: A study of individuals with congenital adrenal hyperplasia. Horm. Behav. 50:148–153.
   PubMed Web of Science ®Google Scholar
• Knobloch, H., and Pasamanick, B. 1975. Some etiologic and prognostic factors in early infantile autism and psychosis. Pediatrics. 55:182–191.
   PubMed Web of Science ®Google Scholar
• Koga, K., and Mor, G. 2010. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am. J. Reprod. Immunol. 63:587–600.
   PubMed Web of Science ®Google Scholar
• Kogan, M. D., Blumberg, S. J., Schieve, L. A., Boyle, C. A., Perrin, J. M., Ghandour, R. M., Singh, G. K., Strickland, B. B., Trevathan, E., and van Dyck, P. C. 2009. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 124:1–9.
   Google Scholar
• Kolvin, I. 1971. Studies in the childhood psychoses. I. Diagnostic criteria and classification. Br. J. Psychiatry. 118:381–384.
   PubMed Web of Science ®Google Scholar
• Kotsopoulos, S., and Kutty, K. M. 1979. Histidinemia and infantile autism. J. Autism Dev. Disord. 9:55–60.
   PubMed Web of Science ®Google Scholar
• Landrigan, P. J. 2010. What causes autism? Exploring the environmental contribution. Curr. Opin. Pediatr. 22:219–225.
   PubMed Web of Science ®Google Scholar
• Lewine, J. D., Andrews, R., Chez, M., Patil, A. A., Devinsky, O., Smith, M., Kanner, A., Davis, J. T., Funke, M., Jones, G., Chong, B., Provencal, S., Weisend, M., Lee, R. R., and Orrison, W. W., Jr. 1999. Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics. 104:405–418.
   PubMed Web of Science ®Google Scholar
• Libbey, J. E., Sweeten, T. L., McMahon, W. M., and Fujinami, R. S. 2005. Autistic disorder and viral infections. J. Neurovirol. 11:1–10.
   PubMed Web of Science ®Google Scholar
• London, E. A. 2000. The environment as an etiologic factor in autism: a new direction for research. Environ. Health Perspect. 108 Suppl 3:401–404.
   Google Scholar
• Lord, C., Cook, E. H., Leventhal, B. L., and Amaral, D. G. 2000. Autism spectrum disorders. Neuron. 28:355–363.
   PubMed Web of Science ®Google Scholar
• Loveland, K., and Tunali-Kotoski, B. 2005. The school aged child with an autism spectrum disorder. In: The Handbook of Autism and Pervasive Developmental Disorders, 3rd Edition. Volume 1 (Volkmar, F., Paul, R., Klin, A., and Cohen, D., Eds.), Hoboken, NJ: John Wiley & Sons, Inc., pp. 247–287.
   Google Scholar
• Lowe, T. L., Tanaka, K., Seashore, M. R., Young, J. G., and Cohen, D. J. 1980. Detection of phenylketonuria in autistic and psychotic children. JAMA. 243:126–128.
   Google Scholar
• Madden, N. P., Levinsky, R. J., Bayston, R., Harvey, B., Turner, M. W., and Spitz, L. 1989. Surgery, sepsis, and nonspecific immune function in neonates. J. Pediatr. Surg. 24:562–566.
   Google Scholar
• Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., and Melbye, M. 2002. A population-based study of measles, mumps, and rubella vaccination and autism. N. Engl. J. Med. 347:1477–1482.
   PubMed Web of Science ®Google Scholar
• Makani, S., Gollapudi, S., Yel, L., Chiplunkar, S., and Gupta, S. 2002. Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: a major role of mitochondrial pathway. Genes Immun. 3:270–278.
   PubMed Web of Science ®Google Scholar
• Manning, J. T., Baron-Cohen, S., Wheelwright, S., and Sanders, G. 2001. The 2nd to 4th digit ratio and autism. Dev. Med. Child Neurol. 43:160–164.
   PubMed Web of Science ®Google Scholar
• Mansheim, P. 1979. Tuberous sclerosis and autistic behavior. J. Clin. Psychiatry. 40:97–98.
   Google Scholar
• McDonald, M. E., and Paul, J. F. 2010. Timing of increased autistic disorder cumulative incidence. Environ. Sci. Technol. 44:2112–2118.
   PubMed Web of Science ®Google Scholar
• Megson, M. N. 2000. Is autism a G-alpha protein defect reversible with natural vitamin A? Med. Hypotheses. 54:979–983.
   PubMedGoogle Scholar
• Merck & Co., Inc. 2001. VARIVAX® (Varicella Virus Vaccine Live). 9904702.
   Google Scholar
• Merck & Co., Inc. 2010. M-M-R® II (Measles, Mumps, and Rubella Virus Vaccine Live). 9912201.
   Google Scholar
• Meryash, D. L., Szymanski, L. S., and Gerald, P. S. 1982. Infantile autism associated with the fragile-X syndrome. J. Autism Dev. Disord. 12:295–301.
   Google Scholar
• Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., Yee, B. K., and Feldon, J. 2006. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 26:4752–4762.
   PubMed Web of Science ®Google Scholar
• Ming, X., Brimacombe, M., Malek, J. H., Jani, N., and Wagner, G. C. 2008. Autism spectrum disorders and identified toxic land fills: Co-occurrence across states. Environ. Health Insights 2:55–59.
   Google Scholar
• Morgan, C. N., Roy, M., and Chance, P. 2003. Psychiatric co-morbidity and medication use in autism: A community survey. Psychiat. Bull. 27:378–381.
   Google Scholar
• Muhle, R., Trentacoste, S. V., and Rapin, I. 2004. The genetics of autism. Pediatrics. 113:e472–e486.
   PubMed Web of Science ®Google Scholar
• Mutkus, L., Aschner, J. L., Syversen, T., Shanker, G., Sonnewald, U., and Aschner, M. 2005. In vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells is inhibited by the ethylmercury-containing preservative thimerosal. Biol. Trace Elem. Res. 105:71–86.
   PubMed Web of Science ®Google Scholar
• Nataf, R., Skorupka, C., Amet, L., Lam, A., Springbett, A., and Lathe, R. 2006. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol. Appl. Pharmacol. 214:99–108.
   PubMed Web of Science ®Google Scholar
• Nataf, R., Skorupka, C., Lam, A., Springbett, A., and Lathe, R. 2008. Porphyrinuria in childhood autistic disorder is not associated with urinary creatinine deficiency. Pediatr. Int. 50:528–532.
   PubMed Web of Science ®Google Scholar
• Nedic, G., Pivac, N., Hercigonja, D. K., Jovancevic, M., Curkovic, K. D., and Muck-Seler, D. 2010. Platelet monoamine oxidase activity in children with attention-deficit/hyperactivity disorder. Psychiatry Res. 175:252–255.
   Google Scholar
• Orlowski, J. P., Hanhan, U. A., and Fiallos, M. R. 2002. Is aspirin a cause of Reye’s syndrome? A case against. Drug Saf. 25:225–231.
   Google Scholar
• Ornitz, E. M. 1983. The functional neuroanatomy of infantile autism. Int. J. Neurosci. 19:85–124.
   PubMed Web of Science ®Google Scholar
• Ornitz, E. M., Guthrie, D., and Farley, A. H. 1977. The early development of autistic children. J. Autism Child. Schizophr. 7:207–229.
   PubMedGoogle Scholar
• Parker, S. K., Schwartz, B., Todd, J., and Pickering, L. K. 2004. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 114:793–804.
   PubMed Web of Science ®Google Scholar
• Parker-Athill, E. C., and Tan, J. 2010. Maternal Immune Activation and Autism Spectrum Disorder: Interleukin-6 Signaling as a Key Mechanistic Pathway. Neurosignals (In Press).
   Google Scholar
• Parran, D. K., Barker, A., and Ehrich, M. 2005. Effects of thimerosal on NGF signal transduction and cell death in neuroblastoma cells. Toxicol. Sci. 86:132–140.
   PubMed Web of Science ®Google Scholar
• Pasca, A. M., and Penn, A. A. 2010. The placenta: The lost neuroendocrine organ. NeoRev. 11:e64–e77.
   Google Scholar
• Paul, R. (Ed). 1987. Natural History. In: Handbook of Autism and Pervasive Developmental Disorders, New York: John Wiley & Sons, Inc., pp. 121–123.
   Google Scholar
• Polleux, F., and Lauder, J. M. 2004. Toward a developmental neurobiology of autism. Ment. Retard. Dev. Disabil. Res. Rev. 10:303–317.
   PubMedGoogle Scholar
• Pons, R., Andreu, A. L., Checcarelli, N., Vilà, M. R., Engelstad, K., Sue, C. M., Shungu, D., Haggerty, R., de Vivo, D. C., and DiMauro, S. 2004. Mitochondrial DNA abnormalities and autistic spectrum disorders. J. Pediatr. 144:81–85.
   Google Scholar
• Posey, D. J., Stigler, K. A., Erickson, C. A., and McDougle, C. J. 2008. Antipsychotics in the treatment of autism. J. Clin. Invest. 118:6–14.
   PubMed Web of Science ®Google Scholar
• Ramsay, M. E., Corbel, M. J., Redhead, K., Ashworth, L. A., and Begg, N. T. 1991. Persistence of antibody after accelerated immunization with diphtheria/tetanus/pertussis vaccine. Br. Med. J. 302:1489. DOI: 10.1136/bmj.302.6791.1489.
   PubMedGoogle Scholar
• Ratajczak, H. V. 2011. Theoretical aspects of autism: Biomarkers—A review. J. Immunotoxicol. (In Press).
   Google Scholar
• Reichenberg, A., Gross, R., Weiser, M., Bresnahan, M., Silverman, J., Harlap, S., Rabinowitz, J., Shulman, C., Malaspina, D., Lubin, G., Knobler, H. Y., Davidson, M., and Susser, E. 2006. Advancing paternal age and autism. Arch. Gen. Psychiatry. 63:1026–1032.
   PubMed Web of Science ®Google Scholar
• Rice, C. 2009. Prevalence of Autism Spectrum Disorders—Autism and Developmental Disabilities Monitoring Network, United States, 2006. Available on-line at: www.cdc.gov/mmwr/preview/mmwrhtml/ss5810al.htm, pp. 1–21
   Google Scholar
• Robinson, P. D., Schutz, C. K., Macciardi, F., White, B. N., and Holden, J. J. 2001. Genetically determined low maternal serum dopamine beta-hydroxylase levels and the etiology of autism spectrum disorders. Am. J. Med. Genet. 100:30–36.
   Google Scholar
• Rodier, P. M. 2000. The early origins of autism. Sci. Am. 282:56–63.
   PubMed Web of Science ®Google Scholar
• Román, G. C. 2007. Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents. J. Neurol. Sci. 262:15–26.
   PubMed Web of Science ®Google Scholar
• Rosales, F. J. 2002. Vitamin a supplementation of vitamin a deficient measles patients lowers the risk of measles-related pneumonia in zambian children. J. Nutr. 132:3700–3703.
   Google Scholar
• Rossignol, D. 2007. The use of urinary porphyrins analysis in autism. Int. Child. Dev. Resource Center Jan. 14, pp. 1–9.
   Google Scholar
• Rossignol, D. A., and Bradstreet, J. J. 2008. Evidence of mitochondrial dysfunction in autism and implications for treatment. Am J. Biochem. Biotech. 4:208–217.
   Google Scholar
• Schechter, R., and Grether, J. K. 2008. Continuing increases in autism reported to California’s developmental services system: mercury in retrograde. Arch. Gen. Psychiatry. 65:19–24.
   PubMed Web of Science ®Google Scholar
• Schonauer, K., Klar, M., Kehrer, H. E., and Arolt, V. 2001. [The course of infantile autism through adulthood. An overview of long-term follow-up data]. Fortschr. Neurol. Psychiatr. 69:221–235.
   Google Scholar
• Schultz, S. T. 2010. Can autism be triggered by acetaminophen activation of the endocannabinoid system? Acta Neurobiol. Exp. (Wars). 70:227–231.
   Google Scholar
• Schultz, S. T., Klonoff-Cohen, H. S., Wingard, D. L., Akshoomoff, N. A., Macera, C. A., and Ji, M. 2008. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey. Autism. 12:293–307.
   PubMed Web of Science ®Google Scholar
• Shelton, J. F., Tancredi, D. J., and Hertz-Picciotto, I. 2010. Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res. 3:30–39.
   PubMed Web of Science ®Google Scholar
• Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., and Cole, P. 1993. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 7:97–103.
   PubMed Web of Science ®Google Scholar
• Singh, V. K., Lin, S. X., and Yang, V. C. 1998. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin. Immunol. Immunopathol. 89:105–108.
   PubMedGoogle Scholar
• Singh, V. K., Lin, S. X., Newell, E., and Nelson, C. 2002. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J. Biomed. Sci. 9:359–364.
   PubMed Web of Science ®Google Scholar
• Solomon, J. B. (Ed). 1971. Foetal and Neonatal Immunology. Amsterdam: Elsevier Publishing Co.
   Google Scholar
• Stewart, P., Fitzgerald, S., Reihman, J., Gump, B., Lonky, E., Darvill, T., Pagano, J., and Hauser, P. 2003. Prenatal PCB exposure, the corpus callosum, and response inhibition. Environ. Health Perspect. 111:1670–1677.
   PubMed Web of Science ®Google Scholar
• Strickberger, M. W. (Ed). 1968. Genetics. New York, NY: The Macmillan Company.
   Google Scholar
• Strömland, K., Nordin, V., Miller, M., Akerström, B., and Gillberg, C. 1994. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 36:351–356.
   PubMed Web of Science ®Google Scholar
• Sullivan, M. G. 2005. Autism increase not a result of reclassification. Clin. Psychiat. News. May, p. 68.
   Google Scholar
• Sultatos, L. G. 1994. Mammalian toxicology of organophosphorus pesticides. J. Toxicol. Environ. Health. 43:271–289.
   PubMed Web of Science ®Google Scholar
• Torres, A. R. 2003. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatr. 3:9.
   PubMedGoogle Scholar
• Van Acker, R., Loncola, J. A., and Van Acker, E. Y. 2005. Rett Syndrome: A pervasive developmental disorder In: Handbook of Autism and Pervasive Developmental Disorders. Third Edition, Volume 1 (Volkmar, F. R., Paul, R., Klin, A., and Cohen, D., Eds.), Hoboken, N.J.: John Wiley & Sons Inc., pp. 126–164.
   Google Scholar
• Vincent, J. B., Konecki, D. S., Munstermann, E., Bolton, P., Poustka, A., Poustka, F., and Gurling, H. M. 1996. Point mutation analysis of the FMR-1 gene in autism. Mol. Psychiatry. 1:227–231.
   Google Scholar
• Vojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., and Vojdani, E. 2002. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J. Neuroimmunol. 129:168–177.
   PubMed Web of Science ®Google Scholar
• Volkmar, F. R., and Klin, A. 2005. Issues in the classification of autism and related conditions. In: Handbook of Autism and Pervasive Developmental Disorders, 3rd Edition, Volume 1 (Volkmar, F. R., Paul, R., Klin, A., and Cohen, D., Eds.), Hoboken, NJ: John Wiley & Sons, Inc., pp. 5–41.
   Google Scholar
• Walsh, W. J., Usman, A., and Tarpey, J. 2001. Disordered metal metabolism in a large autism population. Am. Psychiatric Association Meeting May, New Orleans.
   Google Scholar
• Wilson, K., Mills, E., Ross, C., McGowan, J., and Jadad, A. 2003. Association of autistic spectrum disorder and the measles, mumps, and rubella vaccine: a systematic review of current epidemiological evidence. Arch. Pediatr. Adolesc. Med. 157:628–634.
   Google Scholar
• Xanthou, M., Valassi-Adam, E., Kintsonidou, E., and Matsaniotis, N. 1975. Phagocytosis and killing ability of Candida albicans by blood leucocytes of healthy term and preterm babies. Arch. Dis. Child. 50:72–75.
   Google Scholar
• Ziring, P.; Committee on Children with Disabilities. 2001. The pediatrician’s role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 107:1221–1226.
   Google Scholar
• Ziring, P. R. 1977. Congenital rubella: the teenage years. Pediatr. Ann. 6:762–770.
   Google Scholar